HeartSciences Files Preliminary Proxy Statement for Fortitude Business Combination
HeartSciences announced the filing of a preliminary proxy statement for a business combination with Fortitude Mining Holdings. The company also reported that the MyoVista wavECG device was submitted to the FDA while fiscal 2026 financial results were disclosed.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day